Moreover, the down-regulation of the PPAR-γ levels observed in the serum from right-sided colon cancer patients confirms the loss of the PPAR-γ modulators with an inhibitory effect on colon cancer cell proliferation. The gene discussed is PPARG; the disease is colonic neoplasm.